Tools for the prediction of physicochemical properties selected to assist teaching of medicinal chemistry at the Royal Society of Chemistry school.
Advanced Chemistry Development, (ACD/Labs) and the Royal Society of Chemistry (RSC) have announced the incorporation of PhysChem, which offers tools for the prediction of physicochemical properties, into RSC's Medicinal Chemistry School.
For the third year in a row, LogD Sol suite, a module of PhysChem, will be used to assist in the teaching of medicinal chemists.
LogD Sol suite provides a full array of tools for the prediction of physicochemical properties of compounds such as pKa, pH-dependent logD, logP, and aqueous solubility.
"We are naturally very pleased to be part of this important educational forum for tomorrow's leaders in medicinal chemistry," comments Robert DeWitte, director of medicinal chemistry at ACD/Labs. Designed for medicinal chemists, LogD Sol suite will be incorporated into tutorials and presentations to display the importance of physicochemical properties in pharmaceutical research at RSC's Medicinal Chemistry School.
"Through guided hands-on use of ACD/Labs software, we find that people are able to gain an insight into the relationship between the chemical structure of molecules and their associated physicochemical properties," said Rupert Austin, AstraZeneca.
Increasingly, throughout the industry, drug discovery projects are actively aiming to design pharmaceutical properties into their lead candidates, to enhance their likelihood of clinical success.
